Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin induced thrombocytopenia

被引:121
作者
Hong, AP
Cook, DJ
Sigouin, CS
Warkentin, TE
机构
[1] Hamilton Hlth Sci, Hamilton Reg Lab Med Program, Hamilton, ON L8L 2X2, Canada
[2] McMaster Univ, Dept Pathol & Mol Med, Dept Med, Hamilton, ON L8S 4L8, Canada
[3] McMaster Univ, Dept Anaesthesia, Hamilton, ON L8S 4L8, Canada
[4] Univ Hlth Network, Program Hlth Innovat, Toronto, ON, Canada
[5] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
D O I
10.1182/blood-2002-05-1448
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heparin-induced thrombocytopenia (HIT) is a transient antibody-mediated hypercoagulability state strongly associated with lower-limb deep-vein thrombosis (DVT). Whether HIT Is additionally associated With upper-limb DVT-either with or with-out central venous catheter (CVC) use-is unknown. We therefore studied 260 patients With antibody-positive HIT to determine the influence of CVC use :on frequency and localization of upper-extremity DVT in comparison with 2 non-HIT control populations (postoperative orthopedic surgery and intensive-care unit patients). compared with the control populations, both upper- and lower-extremity DVTs were found to be associated With HIT. Upper-extremity DVTs occurred more frequently in HIT patients with a CVC (1 1 4 of 145 [9.7%]) versus none of 115 (0%) patients with but a CVC (P = .00035). All upper-extremity DVTs occurred at the CVC site (right, 12; left, 2; kappa = 1.0; P = .011). We conclude that a localizing vascular injury (CVC use), and a systemic hypercoagulability disorder (HIT) interact to explain upper-extremity DVT complicating HIT. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3049 / 3051
页数:3
相关论文
共 14 条
[1]  
CHONG BH, 1982, LANCET, V2, P1246
[2]  
COOK D, IN PRESS CRIT CARE
[3]   Upper-extremity deep vein thrombosis [J].
Elliott, G .
LANCET, 1997, 349 (9060) :1188-1189
[4]   Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range [J].
Greinacher, A ;
Eichler, P ;
Lubenow, N ;
Kwasny, H ;
Luz, M .
BLOOD, 2000, 96 (03) :846-851
[5]   Upper extremity deep venous thrombosis: An underrecognized manifestation of a hypercoagulable state [J].
Hingorani, A ;
Ascher, E ;
Yorkavich, W ;
Mazzariol, F ;
Jacob, T ;
Gunduz, Y ;
Salles-Cunha, S .
ANNALS OF VASCULAR SURGERY, 2000, 14 (05) :421-426
[6]   Hypercoagulability states in upper-extremity deep venous thrombosis [J].
Leebeek, FWG ;
Stadhouders, NAM ;
van Stein, D ;
Gómez-García, EB ;
Kappers-Klunne, MC .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 67 (01) :15-19
[7]  
Nand S, 1997, AM J HEMATOL, V56, P12, DOI 10.1002/(SICI)1096-8652(199709)56:1<12::AID-AJH3>3.0.CO
[8]  
2-5
[9]  
Warkentin T.E., 2001, Heparin-Induced Thrombocytopenia, V2nd ed., P43
[10]   Heparin-induced skin lesions [J].
Warkentin, TE .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) :494-497